E-mail marketer Sili Neutraceuticals was fined more than$2.5 million by Federal district court of Northern Illinois for violating the Can-Spam Act by sending e-mails that contained misleading subject lines and didn’t offer an opt-out mechanism. The complaint said that Sili had been marketing Hoodia and human growth hormone supplements since 2004 via e-mail, which contained links to Web sites that made false claims about the product.
Related Posts
Google expert advises on hyphenated domain names
Renowned Google SEO specialist, John Mueller, recently addressed hyphenated domain names. A topic raised by a Reddit user…
Google prioritizes user-centric quality content
In an increasingly competitive online landscape, generating enlightening, reliable, and user-centric content has become essential. This content, known…
Unequal financial burdens amplify call for reform
Financial difficulties are not evenly distributed in society, with lower-income individuals often faced with higher economic burdens than…